AIMP1 and pulmonary emphysema: In mouse models, EMAP II is necessary and sufficient for the development of emphysema (112, 113); it also has established roles in HIV-associated pulmonary vascular disease, and in endothelial cell death and inflammation, which are three key players in PH (112, 114–116).